Clinical Trial Update: Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant chemotherapy study for non-metastatic non-small cell lung cancer was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Western Regional Medical Center | Conditions: Non-squamous Cell Non-Metastatic Non-Small Cell Lung Cancer, Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-10-25